Abstract
In a double-blind trial the effect on ventilatory function of oral salbutamol (in two different doses) and a placebo were studied in 12 patients with chronic asthma receiving regular maintenance treatment with prednisolone. Salbutamol in a dose of 4 mg four times daily, given for a period of four weeks, produced a sustained and statistically significant increase in peak expiratory flow rate over the pretreatment recordings. This effect was not observed with a lower dose of salbutamol (2 mg four times daily) or with a placebo. Salbutamol in the higher dose would seem to be an effective and safe oral bronchodilator that can be recommended for the treatment of mild or moderate asthma. The duration of treatment in this study was, however, limited to four weeks, and it is not known whether effective bronchodilatation would be maintained if the drug were given for longer periods.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Choo-Kang Y. F., Parker S. S., Grant I. W. Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J. 1970 Nov 21;4(5733):465–468. doi: 10.1136/bmj.4.5733.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choo-Kang Y. F., Simpson W. T., Grant I. W. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J. 1969 May 3;2(5652):287–289. doi: 10.1136/bmj.2.5652.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ENGELHARDT A., HOEFKE W., WICK H. [On the pharmacology of the sympathomimetic 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane]. Arzneimittelforschung. 1961 Jun;11:521–525. [PubMed] [Google Scholar]
- Epstein S. W., Fletcher C. M., Oppenheimer E. A. Daily peak flow measurements in the assessment of steroid therapy for airway obstruction. Br Med J. 1969 Jan 25;1(5638):223–225. doi: 10.1136/bmj.1.5638.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUME K. M., GANDEVIA B. Forced expiratory volume before and after isoprenaline. Thorax. 1957 Sep;12(3):276–278. doi: 10.1136/thx.12.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heaf P. J., Mattila M. J. Assessment of bronchodilator drugs on asthmatic out-patients by daily measurements of the peak expiratory flow rate. Arzneimittelforschung. 1969 Dec;19(12):1927–1929. [PubMed] [Google Scholar]
- Kamburoff P. L., Rime F. J. Oral and inhaled salbutamol as a bronchodilator. Br J Dis Chest. 1970 Jan;64(1):46–54. doi: 10.1016/s0007-0971(70)80048-1. [DOI] [PubMed] [Google Scholar]
- Kennedy M. C., Simpson W. T. Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator. Br J Dis Chest. 1969 Jul;63(3):165–174. doi: 10.1016/s0007-0971(69)80014-8. [DOI] [PubMed] [Google Scholar]